{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:21:04Z","timestamp":1780579264761,"version":"3.54.1"},"reference-count":159,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.tins.2008.02.005","type":"journal-article","created":{"date-parts":[[2008,4,8]],"date-time":"2008-04-08T10:39:38Z","timestamp":1207651178000},"page":"234-242","source":"Crossref","is-referenced-by-count":861,"title":["Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia"],"prefix":"10.1016","volume":"31","author":[{"given":"John E.","family":"Lisman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Javitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine M.","family":"Benes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Heckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2008.02.005_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Perala","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","article-title":"Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence","volume":"10","author":"Harrison","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib3","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI24759","article-title":"Finding schizophrenia genes","volume":"115","author":"Kirov","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tins.2008.02.005_bib4","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/archneur.63.10.1372","article-title":"Cognitive dysfunction in schizophrenia: convergence of \u03b3-aminobutyric acid and glutamate alterations","volume":"63","author":"Lewis","year":"2006","journal-title":"Arch. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.tins.2008.02.005_bib5","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1055\/s-2006-931483","article-title":"The neurochemical circuitry of schizophrenia","volume":"39","author":"Carlsson","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(79)90767-0","article-title":"\u03b3-Aminobutyric-acid deficiency in brain of schizophrenic patients","volume":"1","author":"Perry","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.tins.2008.02.005_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/070674378503000407","article-title":"Computed tomographic brain studies and treatment response in schizophrenia","volume":"30","author":"Bird","year":"1985","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0304-3940(89)90819-7","article-title":"Reduced GABA uptake sites in the temporal lobe in schizophrenia","volume":"107","author":"Simpson","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2008.02.005_bib9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archpsyc.1995.03950160008002","article-title":"Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics","volume":"52","author":"Akbarian","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archpsyc.57.3.237","article-title":"Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical \u03b3-aminobutyric acid neurons in subjects with schizophrenia","volume":"57","author":"Volk","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpsyc.59.6.521","article-title":"Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia","volume":"59","author":"Heckers","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archpsyc.61.7.649","article-title":"Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder","volume":"61","author":"Woo","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1176\/appi.ajp.158.2.256","article-title":"GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons","volume":"158","author":"Volk","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib15","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archpsyc.1991.01810350036005","article-title":"Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients","volume":"48","author":"Benes","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib16","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1073\/pnas.95.9.5341","article-title":"A subclass of prefrontal \u03b3-aminobutyric acid axon terminals are selectively altered in schizophrenia","volume":"95","author":"Woo","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2008.02.005_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00188-8","article-title":"A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia","volume":"55","author":"Zhang","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.tins.2008.02.005_bib18","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1176\/ajp.154.7.1013","article-title":"Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons","volume":"154","author":"Woo","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib20","first-page":"203","article-title":"Regional survey of GABA-related gene expression in the neocortex of subjects with schizophrenia","volume":"33","author":"Hashimoto","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.tins.2008.02.005_bib21","doi-asserted-by":"crossref","first-page":"10164","DOI":"10.1073\/pnas.0703806104","article-title":"Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars","volume":"104","author":"Benes","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2008.02.005_bib22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/(SICI)1098-2396(199604)22:4<338::AID-SYN5>3.0.CO;2-C","article-title":"Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain","volume":"22","author":"Benes","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.tins.2008.02.005_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pnpbp.2006.07.004","article-title":"Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia","volume":"31","author":"Newell","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0306-4522(99)00189-X","article-title":"Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor \u03b1-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression","volume":"93","author":"Ohnuma","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2008.02.005_bib25","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cercor\/12.10.1063","article-title":"Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia","volume":"12","author":"Volk","year":"2002","journal-title":"Cereb. Cortex"},{"issue":"Suppl.","key":"10.1016\/j.tins.2008.02.005_bib26","first-page":"1515","article-title":"Cingulate cortex GABA concentration in schizophrenia: a two-dimensional proton magnetic resonance spectroscopy study","volume":"59","author":"Rosso","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archpsyc.59.4.347","article-title":"Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation","volume":"59","author":"Daskalakis","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.57.12.1139","article-title":"Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia","volume":"57","author":"Umbricht","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-005-0177-2","article-title":"The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers","volume":"183","author":"Parwani","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tins.2008.02.005_bib32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/archpsyc.1991.01810310036007","article-title":"Neuropsychological function in schizophrenia. Selective impairment in memory and learning","volume":"48","author":"Saykin","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.npp.1380271","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2008.02.005_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81972-8","article-title":"Mice with reduced NMDA receptor expression display behaviors related to schizophrenia","volume":"98","author":"Mohn","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.tins.2008.02.005_bib35","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1523\/JNEUROSCI.22-15-06713.2002","article-title":"Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity","volume":"22","author":"Ballard","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib36","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.1073\/pnas.93.21.11962","article-title":"Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia","volume":"93","author":"Javitt","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2008.02.005_bib37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0006-3223(91)90126-7","article-title":"Mismatch negativity: an index of a preattentive processing deficit in schizophrenia","volume":"30","author":"Shelley","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145703003900","article-title":"Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms","volume":"7","author":"Sumiyoshi","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tins.2008.02.005_bib39","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1176\/appi.ajp.162.9.1738","article-title":"Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type","volume":"162","author":"Neeman","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","article-title":"Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia","volume":"60","author":"Hashimoto","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib41","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archpsyc.1995.03950220039008","article-title":"Abnormal excitatory neurotransmitter metabolism in schizophrenic brains","volume":"52","author":"Tsai","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4615-0135-0_18","article-title":"Kynurenic acid and schizophrenia","volume":"527","author":"Erhardt","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tins.2008.02.005_bib43","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/PL00000638","article-title":"Redox modulation of the NMDA receptor","volume":"57","author":"Choi","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tins.2008.02.005_bib44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrn2153","article-title":"NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders","volume":"8","author":"Lau","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib45","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1152\/jn.00680.2002","article-title":"Glycine transporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo","volume":"89","author":"Chen","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tins.2008.02.005_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00213-003-1709-2","article-title":"The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia","volume":"174","author":"Coyle","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tins.2008.02.005_bib47","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biopsych.2006.04.005","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia","volume":"60","author":"Lane","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib48","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.biopsych.2003.09.012","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia","volume":"55","author":"Tsai","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib49","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2008.02.005_bib50","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.tins.2008.02.005_bib51","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1152\/jn.00875.2004","article-title":"Activation of metabotropic glutamate 2\/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats","volume":"93","author":"Homayoun","year":"2005","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tins.2008.02.005_bib52","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1113\/jphysiol.2003.056812","article-title":"Group II metabotropic glutamate receptors enhance NMDA receptor currents via a protein kinase C-dependent mechanism in pyramidal neurones of rat prefrontal cortex","volume":"554","author":"Tyszkiewicz","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.tins.2008.02.005_bib53","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1523\/JNEUROSCI.16-06-02034.1996","article-title":"NMDA-dependent modulation of CA1 local circuit inhibition","volume":"16","author":"Grunze","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0304-3940(93)90341-H","article-title":"Basket-like interneurones in layer II of the entorhinal cortex exhibit a powerful NMDA-mediated synaptic excitation","volume":"149","author":"Jones","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2008.02.005_bib55","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0896-6273(02)00608-6","article-title":"Distinct NMDA receptors provide differential modes of transmission at mossy fiber-interneuron synapses","volume":"33","author":"Lei","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2008.02.005_bib56","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1523\/JNEUROSCI.22-13-05462.2002","article-title":"Control of feedforward dendritic inhibition by NMDA receptor-dependent spike timing in hippocampal interneurons","volume":"22","author":"Maccaferri","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1113\/jphysiol.2004.078915","article-title":"Defined types of cortical interneurone structure space and spike timing in the hippocampus","volume":"562","author":"Somogyi","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.tins.2008.02.005_bib58","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/(SICI)1098-1063(1996)6:3<294::AID-HIPO7>3.0.CO;2-N","article-title":"Physiological properties of anatomically identified basket and bistratified cells in the CA1 area of the rat hippocampus in vitro","volume":"6","author":"Buhl","year":"1996","journal-title":"Hippocampus"},{"key":"10.1016\/j.tins.2008.02.005_bib59","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1523\/JNEUROSCI.4409-05.2006","article-title":"NMDA receptors in layer 4 spiny stellate cells of the mouse barrel cortex contain the NR2C subunit","volume":"26","author":"Binshtok","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib60","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1073\/pnas.0308455101","article-title":"NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex","volume":"101","author":"Jackson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2008.02.005_bib61","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10571-004-6918-7","article-title":"Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia","volume":"24","author":"Vaisanen","year":"2004","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.tins.2008.02.005_bib62","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0166-2236(00)01817-8","article-title":"Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?","volume":"24","author":"Sharp","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib63","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib64","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.tins.2008.02.005_bib65","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/brain\/115.2.367","article-title":"The left medial temporal region and schizophrenia. A PET study","volume":"115","author":"Friston","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.tins.2008.02.005_bib66","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.biopsych.2004.09.013","article-title":"Resting neural activity distinguishes subgroups of schizophrenia patients","volume":"56","author":"Malaspina","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib67","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/1137","article-title":"Impaired recruitment of the hippocampus during conscious recollection in schizophrenia","volume":"1","author":"Heckers","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib68","unstructured":"Lewandowski, N.M. et al. (2005) Isolating hippocampal subregions most vulnerable to schizophrenia. In 2005 Annual Society for Neuroscience Meeting in Washington, DC, Poster\/Program 443.1"},{"key":"10.1016\/j.tins.2008.02.005_bib69","unstructured":"Schobel, S.A. et al. (2007) The CA1 subfield is a primary site of hippocampal dysfunction associated with schizophrenia. In 2007 Annual Society for Neuroscience Meeting in San Diego, CA, Abstract\/Program 806.9\/V27"},{"key":"10.1016\/j.tins.2008.02.005_bib70","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.yebeh.2007.02.014","article-title":"Psychosis: atypical limbic epilepsy versus limbic hyperexcitability with onset at puberty?","volume":"10","author":"Sharp","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.tins.2008.02.005_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.38488.462037.8F","article-title":"Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study","volume":"331","author":"Qin","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.tins.2008.02.005_bib72","series-title":"Epilepsy and Psychiatry","author":"Ounsted","year":"1981"},{"key":"10.1016\/j.tins.2008.02.005_bib73","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1523\/JNEUROSCI.5054-05.2006","article-title":"Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness","volume":"26","author":"Cunningham","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib74","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/28179","article-title":"Cholinergic induction of network oscillations at 40Hz in the hippocampus in vitro","volume":"394","author":"Fisahn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.tins.2008.02.005_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrn2044","article-title":"Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks","volume":"8","author":"Bartos","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib76","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.npp.1300031","article-title":"Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs","volume":"28","author":"Cochran","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2008.02.005_bib77","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.neuroscience.2004.03.039","article-title":"Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia","volume":"126","author":"Keilhoff","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2008.02.005_bib78","doi-asserted-by":"crossref","first-page":"13301","DOI":"10.1073\/pnas.0506034102","article-title":"Regulation of synaptic plasticity in a schizophrenia model","volume":"102","author":"Gisabella","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2008.02.005_bib79","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1523\/JNEUROSCI.4722-05.2006","article-title":"A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons","volume":"26","author":"Kinney","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1113\/jphysiol.2003.042598","article-title":"Ca2+ imaging of mouse neocortical interneurone dendrites: contribution of Ca2+-permeable AMPA and NMDA receptors to subthreshold Ca2+ dynamics","volume":"551","author":"Goldberg","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.tins.2008.02.005_bib81","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1126\/science.1148045","article-title":"Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase","volume":"318","author":"Behrens","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.tins.2008.02.005_bib82","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1523\/JNEUROSCI.3748-04.2005","article-title":"Developmental changes in parvalbumin regulate presynaptic Ca2+ signaling","volume":"25","author":"Collin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib83","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/320750a0","article-title":"Reduction in number of immunostained GABAergic neurones in deprived-eye dominance columns of monkey area 17","volume":"320","author":"Hendry","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.tins.2008.02.005_bib84","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1523\/JNEUROSCI.2478-06.2006","article-title":"Major effects of sensory experiences on the neocortical inhibitory circuits","volume":"26","author":"Jiao","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","article-title":"Dopamine receptors and the dopamine hypothesis of schizophrenia","volume":"1","author":"Seeman","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.tins.2008.02.005_bib86","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1176\/ajp.133.2.197","article-title":"The dopamine hypothesis of schizophrenia: focus on the dopamine receptor","volume":"133","author":"Snyder","year":"1976","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib87","series-title":"Amphetamine and Its Analogs","first-page":"387","article-title":"Amphetamine psychosis: clinical variations of the syndrome","author":"Angrist","year":"1994"},{"key":"10.1016\/j.tins.2008.02.005_bib88","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","volume":"93","author":"Laruelle","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2008.02.005_bib89","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia\u2014implications for schizophrenia and Parkinson's disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","article-title":"Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia","volume":"41","author":"Grace","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2008.02.005_bib91","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1748-1716.1990.tb08955.x","article-title":"Phencyclidine activates rat A10 dopamine neurons but reduces burst activity and causes regularization of firing","volume":"139","author":"Pawlowski","year":"1990","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.tins.2008.02.005_bib92","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-3956(99)00031-X","article-title":"Effects of (S)-ketamine on striatal dopamine: a 11Craclopride PET study of a model psychosis in humans","volume":"34","author":"Vollenweider","year":"2000","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.tins.2008.02.005_bib93","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-005-0092-6","article-title":"Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man","volume":"182","author":"Aalto","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tins.2008.02.005_bib94","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/syn.10010","article-title":"NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans","volume":"43","author":"Kegeles","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.tins.2008.02.005_bib95","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/archpsyc.1995.03950190032005","article-title":"Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia","volume":"52","author":"Javitt","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib96","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1176\/appi.ajp.164.3.474","article-title":"The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents","volume":"164","author":"Leitman","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib97","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/brain\/awl233","article-title":"Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments","volume":"130","author":"Butler","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.tins.2008.02.005_bib98","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0896-6273(95)90304-6","article-title":"Cellular basis of working memory","volume":"14","author":"Goldman-Rakic","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2008.02.005_bib99","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0920-9964(02)00386-9","article-title":"Auditory hallucinations and cognitive impairment in a patient with a lesion restricted to the hippocampus","volume":"64","author":"Suzuki","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.tins.2008.02.005_bib100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0920-9964(01)00399-1","article-title":"Unilateral auditory hallucinations in schizophrenia after damage to the right hippocampus","volume":"58","author":"Takebayashi","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.tins.2008.02.005_bib101","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1523\/JNEUROSCI.21-13-04915.2001","article-title":"Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons","volume":"21","author":"Floresco","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib102","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1523\/JNEUROSCI.20-04-01635.2000","article-title":"Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area","volume":"20","author":"Legault","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib103","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biopsych.2006.01.003","article-title":"A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia","volume":"60","author":"Moore","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib104","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.32620","article-title":"Methylazoxymethanol treatment of fetal rats results in abnormally dense noradrenergic innervation of neocortex","volume":"203","author":"Johnston","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.tins.2008.02.005_bib105","doi-asserted-by":"crossref","first-page":"11424","DOI":"10.1523\/JNEUROSCI.2847-07.2007","article-title":"Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia","volume":"27","author":"Lodge","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib106","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2005.05.002","article-title":"The hippocampal-VTA loop: controlling the entry of information into long-term memory","volume":"46","author":"Lisman","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2008.02.005_bib107","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.neuron.2006.06.021","article-title":"Absolute coding of stimulus novelty in the human substantia nigra\/VTA","volume":"51","author":"Bunzeck","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2008.02.005_bib108","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/hipo.1071","article-title":"Storage, recall, and novelty detection of sequences by the hippocampus: elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine","volume":"11","author":"Lisman","year":"2001","journal-title":"Hippocampus"},{"key":"10.1016\/j.tins.2008.02.005_bib109","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1124\/jpet.105.091579","article-title":"Dopamine-mediated disinhibition in the CA1 region of rat hippocampus via D3 receptor activation","volume":"316","author":"Hammad","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tins.2008.02.005_bib110","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.biopsych.2005.01.033","article-title":"Sustained activation of the hippocampus in response to fearful faces in schizophrenia","volume":"57","author":"Holt","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib111","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(00)00139-0","article-title":"Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia","volume":"49","author":"Braff","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.tins.2008.02.005_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2004.05.006","article-title":"The principal features and mechanisms of dopamine modulation in the prefrontal cortex","volume":"74","author":"Seamans","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.tins.2008.02.005_bib113","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-0173(02)00220-5","article-title":"Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia","volume":"41","author":"Lee","year":"2003","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.tins.2008.02.005_bib114","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.clinph.2004.03.013","article-title":"Reduced oscillatory gamma-band responses in unmedicated schizophrenic patients indicate impaired frontal network processing","volume":"115","author":"Gallinat","year":"2004","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.tins.2008.02.005_bib115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.neuron.2007.01.031","article-title":"Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior","volume":"53","author":"Fuchs","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2008.02.005_bib116","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hipo.20121","article-title":"The theta\/gamma discrete phase code occuring during the hippocampal phase precession may be a more general brain coding scheme","volume":"15","author":"Lisman","year":"2005","journal-title":"Hippocampus"},{"key":"10.1016\/j.tins.2008.02.005_bib117","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archpsyc.62.5.495","article-title":"Early-stage visual processing and cortical amplification deficits in schizophrenia","volume":"62","author":"Butler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib118","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0074-7742(06)78008-4","article-title":"Schizophrenia and the \u03b17 nicotinic acetylcholine receptor","volume":"78","author":"Martin","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.tins.2008.02.005_bib119","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/schbul\/22.3.405","article-title":"Smoking and vulnerability for schizophrenia","volume":"22","author":"de Leon","year":"1996","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.tins.2008.02.005_bib120","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neubiorev.2005.02.006","article-title":"Nicotine use in schizophrenia: the self medication hypotheses","volume":"29","author":"Kumari","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tins.2008.02.005_bib121","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.npp.1301423","article-title":"The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls","volume":"33","author":"Barr","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2008.02.005_bib122","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.biopsych.2003.12.023","article-title":"Nicotine effects on brain function and functional connectivity in schizophrenia","volume":"55","author":"Jacobsen","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib123","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.npp.1300881","article-title":"Effects of nicotine nasal spray on cognitive function in schizophrenia","volume":"31","author":"Smith","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2008.02.005_bib124","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0891-0618(01)00112-0","article-title":"Parvalbumin-containing interneurons of the human cerebral cortex express nicotinic acetylcholine receptor proteins","volume":"21","author":"Krenz","year":"2001","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.tins.2008.02.005_bib125","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/00001756-200105250-00012","article-title":"Tetrodotoxin-sensitive enhancement of inhibition in CA1 pyramidal neurones by nicotine","volume":"12","author":"Hulo","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.tins.2008.02.005_bib126","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1523\/JNEUROSCI.1732-07.2007","article-title":"Cholinergic axons modulate GABAergic signaling among hippocampal interneurons via postsynaptic \u03b1 7 nicotinic receptors","volume":"27","author":"Wanaverbecq","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib127","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.neuropharm.2005.01.003","article-title":"Role of \u03b17-nicotinic acetylcholine receptors in tetanic stimulation-induced gamma oscillations in rat hippocampal slices","volume":"48","author":"Song","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tins.2008.02.005_bib128","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.mp.4001886","article-title":"Six degrees of separation: on the prior probability that schizophrenia susceptibility genes converge on synapses, glutamate and NMDA receptors","volume":"11","author":"Harrison","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/syn.20164","article-title":"Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia","volume":"57","author":"Gupta","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.tins.2008.02.005_bib130","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1073\/pnas.182412499","article-title":"Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia","volume":"99","author":"Chumakov","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2008.02.005_bib131","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.pnpbp.2005.04.023","article-title":"Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients","volume":"29","author":"Hashimoto","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib132","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1073\/pnas.1237052100","article-title":"D-serine and serine racemase are present in the vertebrate retina and contribute to the physiological activation of NMDA receptors","volume":"100","author":"Stevens","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2008.02.005_bib133","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2006.01.019","article-title":"G72\/G30 in schizophrenia and bipolar disorder: review and meta-analysis","volume":"60","author":"Detera-Wadleigh","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib134","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/374822","article-title":"Polymorphisms at the G72\/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series","volume":"72","author":"Hattori","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tins.2008.02.005_bib135","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0006-3223(98)00279-0","article-title":"D-serine added to antipsychotics for the treatment of schizophrenia","volume":"44","author":"Tsai","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib136","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1176\/appi.ajp.159.3.480","article-title":"Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia","volume":"159","author":"Heresco-Levy","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib137","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ajmg.b.30452","article-title":"Evidence for association and epistasis at the DAOA\/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample","volume":"144","author":"Corvin","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.tins.2008.02.005_bib138","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2006.10.010","article-title":"A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia","volume":"90","author":"Bendikov","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.tins.2008.02.005_bib139","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02685890","article-title":"Association analyses of the DAOA\/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia","volume":"9","author":"Shinkai","year":"2007","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.tins.2008.02.005_bib140","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.biopsych.2006.07.025","article-title":"A genetic variant of the serine racemase gene is associated with schizophrenia","volume":"61","author":"Morita","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib141","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/sj.mp.4001776","article-title":"Serine racemase binds to PICK1: potential relevance to schizophrenia","volume":"11","author":"Fujii","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib142","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1471-4159.1997.69010174.x","article-title":"N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells","volume":"69","author":"Wroblewska","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2008.02.005_bib143","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1073\/pnas.081071198","article-title":"Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia","volume":"98","author":"Hakak","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2008.02.005_bib144","unstructured":"Huffacker, S. et al. (2003) Large scale gene chip analysis of post-mortem brains from schizophrenia and bipolar affect in disorder patients. In 2003 Annual Society for Neuroscience Meeting in New Orleans, LA, Abstract\/Program 312.16"},{"key":"10.1016\/j.tins.2008.02.005_bib145","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/schbul\/sbi061","article-title":"Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia?","volume":"31","author":"Williams","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.tins.2008.02.005_bib146","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/hmg\/ddh280","article-title":"Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia","volume":"13","author":"Numakawa","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2008.02.005_bib147","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1172\/JCI200420425","article-title":"Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia","volume":"113","author":"Talbot","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tins.2008.02.005_bib148","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2006.09.008","article-title":"DTNBP1 genotype influences cognitive decline in schizophrenia","volume":"89","author":"Burdick","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.tins.2008.02.005_bib149","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10803-005-0028-3","article-title":"Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS)","volume":"35","author":"Gornick","year":"2005","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.tins.2008.02.005_bib150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/sj.mp.4001608","article-title":"Support for involvement of neuregulin 1 in schizophrenia pathophysiology","volume":"10","author":"Petryshen","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib151","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0014-4827(02)00102-7","article-title":"Neuregulins: functions, forms, and signaling strategies","volume":"284","author":"Falls","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tins.2008.02.005_bib152","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1523\/JNEUROSCI.4314-06.2007","article-title":"Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+\/\u2212 knock-outs compared with wild-type mice","volume":"27","author":"Bjarnadottir","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib153","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuron.2007.03.028","article-title":"The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity","volume":"54","author":"Li","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2008.02.005_bib154","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nm1418","article-title":"Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia","volume":"12","author":"Hahn","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2008.02.005_bib155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0896-6273(00)80454-7","article-title":"A cysteine-rich isoform of neuregulin controls the level of expression of neuronal nicotinic receptor channels during synaptogenesis","volume":"20","author":"Yang","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2008.02.005_bib156","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.1523\/JNEUROSCI.1794-06.2006","article-title":"An acute effect of neuregulin 1 \u03b2 to suppress \u03b1 7-containing nicotinic acetylcholine receptors in hippocampal interneurons","volume":"26","author":"Chang","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2008.02.005_bib157","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.neuron.2007.04.009","article-title":"Neuregulin-1 enhances depolarization-induced GABA release","volume":"54","author":"Woo","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2008.02.005_bib158","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.mp.4001599","article-title":"GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss","volume":"10","author":"Addington","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2008.02.005_bib159","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biopsych.2006.03.054","article-title":"Genetics of chromosome 15q13-q14 in schizophrenia","volume":"60","author":"Leonard","year":"2006","journal-title":"Biol. Psychiatry"}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223608000891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223608000891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T21:07:21Z","timestamp":1557436041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223608000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":159,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0166223608000891"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2008.02.005","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}